Stockhead delves into Elevate Uranium, a company advancing its uranium assets in Namibia, utilising its patented U-pgrade process.

Neurizon recently received EMA orphan designation for NUZ-001 to treat ALS and filed an FDA IND application to begin a phase ...

Cell therapies have suffered from hyped-up expectations, clinical setbacks and high costs. But maybe, just maybe, Arovella is ...

ASX tech rocked a 50pc gain in 2024, Archer Materials shone in December, and Dubber and Brainchip have cashed in on major ...

Ads for AI-related roles are shrinking in Australia, new job data reveals, with the number down 35 per cent compared to over ...

Aussies are missing out on hundreds of thousands of dollars in superannuation returns, according to one of the nation’s largest super funds.

The ASX dipped a tad on Friday, while uranium miners rose after Cameco halted production. Also… news just in – Trudeau looks set to quit.

Summit Minerals led resource gainers after signing a deal to acquire the Mundo Novo niobium and rare earths project in central Brazil.

ASX rides Wall Street’s bounce, energy stocks soar, Insignia jumps on takeover bid and Bellevue Gold takes a dive.

Summit Minerals (ASX:SUM) is looking to acquire the Mundo Novo project in Brazil, which has proven niobium and rare earths ...

Percheron Therapeutics' board of directors has written a letter to shareholders following failure of its phase 2b trial.

Brazilian Critical Minerals is looking forward to a big 2025 in which the market sees the value of its Ema rare earths ...